Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000015

Director sold 2,970 shares at $28.44 ($84,467)

From the SEC's structured data for this filing

Trades in this filing

Krognes Steve E. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-05 Sale : show line 1 in the form −2,970 $28.44 $84,467 146,498 D
Open-market sales · 2,970 sh · avg $28.44 · $84,467
Loading xslF345X03/wf-form4_167331855351574.xml…